GB9720052D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9720052D0
GB9720052D0 GBGB9720052.1A GB9720052A GB9720052D0 GB 9720052 D0 GB9720052 D0 GB 9720052D0 GB 9720052 A GB9720052 A GB 9720052A GB 9720052 D0 GB9720052 D0 GB 9720052D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9720052.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9720052.1A priority Critical patent/GB9720052D0/en
Publication of GB9720052D0 publication Critical patent/GB9720052D0/en
Priority to PCT/EP1998/005904 priority patent/WO1999015526A2/fr
Priority to EP98951421A priority patent/EP1017694A2/fr
Priority to JP2000512831A priority patent/JP2001517668A/ja
Priority to CA002303994A priority patent/CA2303994A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GBGB9720052.1A 1997-09-19 1997-09-19 Novel compounds Ceased GB9720052D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9720052.1A GB9720052D0 (en) 1997-09-19 1997-09-19 Novel compounds
PCT/EP1998/005904 WO1999015526A2 (fr) 1997-09-19 1998-09-15 Nouveaux composes
EP98951421A EP1017694A2 (fr) 1997-09-19 1998-09-15 Derives de la n-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenyluree
JP2000512831A JP2001517668A (ja) 1997-09-19 1998-09-15 Ｎ−５，６，７，８−テトラヒドロ（１、６）ナフチリジン−ｎ’−フェニルウレア誘導体
CA002303994A CA2303994A1 (fr) 1997-09-19 1998-09-15 Nouveaux composes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9720052.1A GB9720052D0 (en) 1997-09-19 1997-09-19 Novel compounds

Publications (1)

Publication Number Publication Date
GB9720052D0 true GB9720052D0 (en) 1997-11-19

Family

ID=10819406

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9720052.1A Ceased GB9720052D0 (en) 1997-09-19 1997-09-19 Novel compounds

Country Status (5)

Country Link
EP (1) EP1017694A2 (fr)
JP (1) JP2001517668A (fr)
CA (1) CA2303994A1 (fr)
GB (1) GB9720052D0 (fr)
WO (1) WO1999015526A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2287170T3 (es) 2000-10-12 2007-12-16 MERCK & CO., INC. Aza- y poliaza-naftalenil-carboxamidas utilies como inhibidores de la vih integrasa.
JP2004517860A (ja) * 2000-10-12 2004-06-17 メルク　エンド　カムパニー　インコーポレーテッド Ｈｉｖインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類
EA200300449A1 (ru) 2000-10-12 2003-10-30 Мерк Энд Ко., Инк. Аза- и полиаза-нафталинилкарбоксамиды, полезные в качестве ингибиторов вич-интегразы
CA2463039A1 (fr) 2001-09-26 2003-04-03 Bayer Pharmaceuticals Corporation Derives de 1,6-naphthyridine et leur utilisation dans le traitement du diabete et de troubles associes
DE60323743D1 (en) 2002-03-15 2008-11-06 Merck & Co Inc N-(substituierte benzyl)-8-hydroxy-1,6-naphthyridin-7- carbonsäureamide als hiv-integrase-hemmer
US8629276B2 (en) * 2012-02-15 2014-01-14 Bristol-Myers Squibb Company Inhibitors of human immunodeficiency virus replication
EP3097101B1 (fr) 2014-01-24 2020-12-23 Merck Sharp & Dohme Corp. Dérivés d'isoquinoline utilisés comme inhibiteurs de mgat2
AU2019390863A1 (en) 2018-11-28 2021-06-24 Takeda Pharmaceutical Company Limited Heterocyclic compound

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1302662B (fr) * 1971-02-04
GB1574019A (en) * 1977-01-14 1980-09-03 Joullie International Sa Therapeutically useful 3,4,5-trimethoxybenzene derivatives
US4542144A (en) * 1981-11-16 1985-09-17 Mcneilab Inc. Anticonvulsant N-aryl-N'-(2-thiazolidinylidene)ureas
PT77429B (fr) * 1982-10-05 1986-02-27 Cortial Procede pour preparer de nouvelles n-(amino-methyl-5 oxazolin-2 yl-2)n'-phenylurees et de compositions les contenant
US5378848A (en) * 1992-02-12 1995-01-03 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
DK41193D0 (da) * 1993-04-07 1993-04-07 Neurosearch As Ionkanalaabnere
GB9511355D0 (en) * 1995-06-06 1995-08-02 Fujisawa Pharmaceutical Co Urea derivatives

Also Published As

Publication number Publication date
WO1999015526A2 (fr) 1999-04-01
JP2001517668A (ja) 2001-10-09
CA2303994A1 (fr) 1999-04-01
EP1017694A2 (fr) 2000-07-12
WO1999015526A3 (fr) 1999-05-20

Similar Documents

Publication Publication Date Title
EG24412A (en) Novel compounds
EG24177A (en) Novel compounds
GB9701684D0 (en) Novel compounds
GB9706255D0 (en) Novel compounds
GB9707830D0 (en) Novel compounds
GB9720052D0 (en) Novel compounds
GB9703492D0 (en) Novel compounds
GB9708174D0 (en) Novel compounds
GB9708034D0 (en) Novel compounds
GB9700688D0 (en) Novel compounds
GB9700687D0 (en) Novel compounds
GB9700694D0 (en) Novel compounds
GB9712581D0 (en) Novel compounds
GB9712557D0 (en) Novel compounds
GB9710165D0 (en) Novel compounds
GB9709521D0 (en) Novel compounds
GB9709520D0 (en) Novel compounds
GB9709463D0 (en) Novel compounds
GB9709094D0 (en) Novel compounds
GB9709089D0 (en) Novel compounds
GB9709085D0 (en) Novel compounds
GB9709083D0 (en) Novel compounds
GB9708492D0 (en) Novel compounds
GB9708491D0 (en) Novel compounds
GB9706525D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)